Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

274.89
+2.010.73%
Volume:84.27K
Turnover:23.06M
Market Cap:13.12B
PE:-56.31
High:276.62
Open:273.35
Low:271.27
Close:272.88
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.41
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.62
PE(LYR):-94.39

Loading ...

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
3 hours ago

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Yesterday

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Charles River Labs to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 11

Evercore ISI Adjusts PT on Charles River Laboratories International to $320 From $300, Maintains Outperform Rating

MT Newswires Live
·
Sep 11

Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 11

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Charles River implements Endosafe Cartridge Technology Automated Manufacturing

TIPRANKS
·
Sep 08

Charles River Expands Endosafe Cartridge Output with Automated Manufacturing Suite

Reuters
·
Sep 08

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

How Investors Are Reacting To Charles River (CRL) Deepening Its Role In Complex Vaccine Development

Simply Wall St.
·
Sep 03

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 01

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Charles River Director James C. Foster Disposes of USD 10.07 Million in Common Shares

Reuters
·
Aug 28

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 25

Is Charles River (CRL) Quietly Redefining Its Edge Through Complex Biologics and Vaccine Testing?

Simply Wall St.
·
Aug 23

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Charles River Labs Director Nancy C. Andrews Disposes of 573 Common Shares Worth $163,442.52

Reuters
·
Aug 21

Charles River Partners with Medigen Vaccine Biologics on NGS-Backed Multivalent Enterovirus Vaccine Development

Reuters
·
Aug 20